Executive Certificate in Health Technology Assessment for Market Access and Reimbursement
Gain expertise in health tech assessment for market access and reimbursement with our Executive Certificate program, enhancing your career prospects and…
Health Technology Assessment (HTA) for Market Access and Reimbursement is a specialized program designed for healthcare professionals, experts , and practitioners seeking to understand the…
Delivered online by London School of International Business, the school behind Healthcare Courses. Ofqual-regulated qualifications with tutor support and flexible payment plans.
Flexible payment plans available · Start studying online immediately after enrolment
Читать эту страницу на следующих языках
Эти варианты только переводят страницу, чтобы вы могли прочитать о программе. Квалификация не меняется.
Это англоязычная квалификация. Все задания выполняются на английском языке. Сертификат выдаётся на английском языке.
Готовим этот язык — страница скоро обновится.
Why enrol on this course?
Health Technology Assessment (HTA) for Market Access and Reimbursement
is a specialized program designed for healthcare professionals, experts, and practitioners seeking to understand the complexities of HTA in the healthcare industry.HTA plays a crucial role in determining the market access and reimbursement of innovative healthcare products, including medical devices, pharmaceuticals, and diagnostic tools.
Through this Executive Certificate program, learners will gain a comprehensive understanding of the HTA process, including the development of economic models, the evaluation of clinical evidence, and the analysis of market trends.
By mastering the skills and knowledge required for HTA, learners will be able to effectively communicate the value of healthcare products to stakeholders, including payers, clinicians, and patients.
Join our program and take the first step towards a career in HTA, where you can make a meaningful impact on the healthcare industry.
About this course
Who is this course for?
| Ideal Audience for Executive Certificate in Health Technology Assessment for Market Access and Reimbursement | Healthcare professionals, particularly those in pharmaceutical, medical device, and biotechnology industries, who want to understand the complexities of health technology assessment and its impact on market access and reimbursement in the UK. |
| Key Characteristics: | Professionals with 5+ years of experience in healthcare, pharmaceutical, or medical device industries, with a strong understanding of healthcare policy, economics, and regulatory frameworks. |
| UK-Specific Statistics: | In 2020, the UK's National Institute for Health and Care Excellence (NICE) approved 74% of new medicines, with an average cost of £20,000 per patient per year. The NHS spends approximately £120 billion annually on healthcare, with 40% of this budget allocated to pharmaceuticals. |
| Learning Objectives: | Upon completion of the Executive Certificate, learners will be able to analyze health technology assessment reports, develop effective market access strategies, and navigate the complex reimbursement landscape in the UK. |
Key facts
The Executive Certificate in Health Technology Assessment for Market Access and Reimbursement is a specialized program designed for healthcare professionals and industry experts who want to gain in-depth knowledge of health technology assessment and its application in market access and reimbursement processes.
This program is offered by top-tier institutions and is typically completed in 6-12 months, depending on the institution and the individual's prior experience and background. The duration of the program allows participants to balance their professional and personal responsibilities while acquiring the necessary skills and knowledge to succeed in the health technology assessment field.
Upon completion of the program, participants can expect to gain a comprehensive understanding of health technology assessment, including the ability to analyze the clinical and economic evidence of medical devices and pharmaceuticals, as well as the regulatory and market access frameworks that govern their approval and reimbursement. This knowledge will enable participants to make informed decisions about the adoption and reimbursement of health technologies, ultimately driving better health outcomes and improved patient care.
The Executive Certificate in Health Technology Assessment for Market Access and Reimbursement is highly relevant to the healthcare industry, particularly in the areas of market access, reimbursement, and health technology assessment. The program's focus on the intersection of clinical, economic, and regulatory factors makes it an attractive option for professionals who want to stay at the forefront of the rapidly evolving healthcare landscape.
The program's industry relevance is further underscored by the fact that many of the world's leading healthcare companies, payers, and regulatory agencies rely on health technology assessment to inform their decisions about the adoption and reimbursement of new health technologies. By acquiring the knowledge and skills necessary to succeed in this field, participants can position themselves for success in a highly competitive and rapidly evolving industry.
Overall, the Executive Certificate in Health Technology Assessment for Market Access and Reimbursement is an excellent option for professionals who want to gain a deeper understanding of the complex factors that influence the adoption and reimbursement of health technologies. With its comprehensive curriculum, flexible duration, and industry relevance, this program is well-positioned to help participants achieve their career goals and make a meaningful impact in the healthcare industry.
Why this course?
| Year | Market Size (£ billion) |
|---|---|
| 2020 | £1.1 billion |
| 2021 | £1.2 billion |
| 2022 | £1.3 billion |
| 2023 | £1.4 billion |
Career path
Course information
Duration
The programme is available in 2 duration modes:
- 1 month
- 2 months
Course delivery
Online
Course content
Healthcare Systems and Reimbursement Models •
Market Access Strategies for Pharmaceuticals •
Health Technology Assessment (HTA) Principles •
Cost-Effectiveness Analysis (CEA) and Economic Evaluation •
Value-Based Reimbursement Models •
Regulatory Frameworks for Medical Devices •
Pharmacoepidemiology and Real-World Evidence •
Healthcare Policy and Decision-Making •
Global Health Technology Assessment and Market Access •
Stakeholder Engagement and Communication in HTA
Assessment
Assessment is via assignment submission.
Fee structure
The fee for the programme is as follows:
- 1 month — Accelerated mode @ GBP £140
- 2 months — Standard mode @ GBP £90
Accreditation
Who delivers this course
- Delivered by
- London School of International Business (LSIB) · UKPRN 10062390
- Awarded by
- an Ofqual-regulated awarding body
- Assessment
- Written assignments, no exams
- Support
- Personal tutor and admissions team, 7 days a week
Your career in health & social care starts here
Flexible online study — enrol in minutes and begin when you are ready.